Zacks Company Profile for Artivion, Inc. (AORT : NYSE) |
|
|
|
Company Description |
Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants. Artivion Inc., formerly known as CryoLife Inc., is headquartered in suburban Atlanta, Georgia.
Number of Employees: 1,600 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $31.46 |
Daily Weekly Monthly
 |
20 Day Moving Average: 336,689 shares |
Shares Outstanding: 42.70 (millions) |
Market Capitalization: $1,343.43 (millions) |
Beta: 1.62 |
52 Week High: $32.94 |
52 Week Low: $21.97 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
11.36% |
6.33% |
12 Week |
37.20% |
15.78% |
Year To Date |
10.04% |
3.39% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
J. Patrick Mackin - President; Chief Executive Officer and Chairman
Lance A. Berry - Chief Financial Officer and Executive Vice Preside
Amy D. Horton - Vice President
Thomas F. Ackerman - Director
Daniel J Bevevino - Director
|
|
Peer Information
Artivion, Inc. (ABMD)
Artivion, Inc. (DMDS)
Artivion, Inc. (CPWY.)
Artivion, Inc. (EQUR)
Artivion, Inc. (ECIA)
Artivion, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 228903100
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
|
|
Share - Related Items
Shares Outstanding: 42.70
Most Recent Split Date: 12.00 (1.50:1)
Beta: 1.62
Market Capitalization: $1,343.43 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.15 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $0.48 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/14/25 |
|
|
|
|